Country for PR: Hong Kong
Contributor: PR Newswire Asia (Hong Kong)
Friday, May 14 2021 - 14:13
AsiaNet
myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program
SINGAPORE, May 14, 2021 /PRNewswire-AsiaNet/ --

Annual Awards Program Recognizes Outstanding Health and Medical Technology 
Products and Companies 

Medidata[https://www.medidata.com/], a Dassault Systemes company, the global 
leader in creating end-to-end solutions supporting the entire clinical trial 
process, today announced that its myMedidata[ 
https://www.medidata.com/en/clinical-trial-products/patient-centric-clinical-trials/mymedidata 
] solution has been selected as the winner of the 'Best Patient Portal' award 
in the fifth annual MedTech Breakthrough Awards program conducted by MedTech 
Breakthrough[ https://medtechbreakthrough.com/ ], an independent market 
intelligence organization that recognizes the top companies, technologies and 
products in the global health and medical technology market.

Medidata's myMedidata is one of the industry's first patient portals to enable 
remote recruitment and virtual participation in clinical trials through a 
single web-based login, accessible on any device. myMedidata delivers a 
streamlined experience for patients and hospitals through one intuitive 
platform, expanding access to all of Medidata's Patient Cloud solutions.

By providing a better overall study experience, patients are more likely to 
actively participate in and remain on their clinical trial. myMedidata was 
built using input from the company's Patient Insights[ 
https://www.medidata.com/en/clinical-trial-solutions/patient-insights] group, 
where patient advocates regularly engage as a part of the Medidata software 
design and development life cycle.

"New drugs and treatments cannot be brought to market without the two most 
important components – the patient and their ability to participate in clinical 
trials. Making research more patient-centric by giving patients the ability to 
virtually access and actively engage in their own treatments and health 
decisions will lead to faster and more effective drug development," said 
Anthony Costello, President of Patient Cloud at Medidata. "We are honored that 
MedTech Breakthrough has recognized myMedidata for this award and we look 
forward to working with more and more of our customers who are actively rolling 
out decentralized trial programs with our technology."

The mission of the MedTech Breakthrough Awards is to honor excellence and 
recognize the innovation, hard work and success in a range of health and 
medical technology categories, including Robotics, Clinical Administration, 
Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, 
Medical Devices, Medical Data and many more. This year's program attracted more 
than 3,850 nominations from over 17 different countries throughout the world.

"By creating a unified patient portal, patients can access all of their trial 
needs in one location, providing patients with the opportunity to view their 
own clinical data and increases their engagement with the study team, tracking 
progress and allowing for continued support throughout the study," said James 
Johnson, Managing Director, MedTech Breakthrough. "This is a true breakthrough 
for an aspect of medicine and healthcare that is so incredibly important today 
and in the future. Congratulations to Medidata for winning our 'Best Patient 
Portal' award this year."

myMedidata provides the industry's single most comprehensive, integrated tool 
set for all aspects of patient-centered research, including electronic consent 
(eConsent) and clinical outcomes assessment (eCOA), wearable sensors, 
myMedidata LIVE (a web-based, live video conferencing capability), and patient 
recruitment/engagement through myMedidata Registries (coming early summer 
2021). myMedidata also includes a research-based COVID-19 Symptom Tracker, 
designed to support research studies and advance scientific understanding of 
the virus.

Medidata is a wholly owned subsidiary of Dassault Systemes, which with its 
3DEXPERIENCE platform is positioned to lead the digital transformation of life 
sciences in the age of personalized medicine with the first end-to-end 
scientific and business platform, from research to commercialization.

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope 
for millions of patients. Medidata helps generate the evidence and insights to 
help pharmaceutical, biotech,  medical device and diagnostics companies, and 
academic researchers accelerate value,  minimize risk, and optimize outcomes. 
More than one million registered users across 1,700+ customers and partners 
access the world's most-used platform for clinical development, commercial, and 
real-world data. Medidata, a Dassault Systemes company (Euronext Paris: #13065, 
DSY.PA), is headquartered in New York City and has offices around the world to 
meet the needs of its customers. Discover more at www.medidata.com and follow 
us @Medidata [http://www.twitter.com/medidata].

Medidata is a registered trademark of Medidata Solutions, Inc., a wholly owned 
subsidiary of Dassault Systemes.

About Dassault Systemes

Dassault Systemes, the 3DEXPERIENCE Company, is a catalyst for human progress. 
We provide business and people with collaborative 3D virtual environments to 
imagine sustainable innovations. By creating virtual experience twins of the 
real world with our 3DEXPERIENCE platform and applications, our customers push 
the boundaries of innovation, learning and production. Dassault Systemes brings 
value to more than 290,000 customers of all sizes, in all industries, in more 
than 140 countries. For more information, visit www.3ds.com.

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, 
SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, 
SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of 
Dassault Systemes, a French "societe europeenne" (Versailles Commercial 
Register # B 322 306 440), or its subsidiaries in the United States and/or 
other countries.

About MedTech Breakthrough

Part of Tech Breakthrough[ https://techbreakthrough.com/ ], a leading market 
intelligence and recognition platform for global technology innovation and 
leadership, the MedTech Breakthrough Awards program is an independent program 
devoted to honoring excellence in medical and health related technology 
companies, products, services and people. The MedTech Breakthrough Awards 
provide a platform for public recognition around the achievements of 
breakthrough health and medical companies and products in categories that 
include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, 
Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more 
information visit MedTechBreakthrough.com[ https://medtechbreakthrough.com/ ].

Contact

Paul Oestreicher
External Communications Director, US
poestreicher@medidata.com

Hanna Skeppner
Corporate Communications Director, EMEA
hskeppner@medidata.com